News

News

Visualisation of SARS-CoV-2 virus with nanobodies

Two of Melbourne’s most prominent medical research and drug development organisations, WEHI and CSL, have joined forces to create a Centre for Biologic Therapies.

19 October 2021
Purple and blue islet cells with red blood vessels

A recent study by WEHI and ENDIA has found type 1 diabetes is associated with changes in the gut microbiome during pregnancy and could contribute to complications in both the mother and baby. 

18 October 2021
A/Prof Wai-Hong Tham photographed in her office

A COVID-19 treatment using monoclonal antibodies is one step closer thanks to the efforts of Australian researchers.

29 September 2021
Researchers from successful round 4 applications from the NDDC

Four research projects have been awarded generous Australian Government subsidies to fast-track their discoveries into new medicines using the National Drug Discovery Centre (NDDC).

21 September 2021
Dr Michael Chopin sitting in front of piece of equipment, smiling at camera

WEHI researchers have made a surprise discovery about how immune ‘sentinel’ cells are maintained, which could have implications for drugs in development for treating cancer.

18 September 2021

Scientists have discovered an important cause of stroke occurring in the womb or just after birth, paving the way for new treatments.

13 September 2021

A study in rural Bangladesh has concluded that preventive iron treatment has no impact on young children’s development.

8 September 2021
Researcher smiling with sign saying "Merck"

An innovative partnership between WEHI and global biopharmaceutical company MSD is advancing research towards new medicines, and upskilling the Australian medical research workforce.

8 September 2021

Melbourne researchers have led a global collaboration to develop a simplified blood test that increases the overall screening efficiency for type 1 diabetes (T1D).

6 September 2021
 Side by side photos of Peter Czabotar and David Komander

The Australian Lead Identification Consortium has announced the completion of the purpose-built Australian Drug Discovery Library, which sees the relocation of more than 329,000 compounds to its new home at Compounds Australia.

3 September 2021

Pages